Post Marketing Surveillance to Observe Safety of Prevenar 13 in Adults
Phase of Trial: Phase IV
Latest Information Update: 21 Apr 2017
Price : $35 *
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Adverse reactions
- Sponsors Pfizer
- 20 Jul 2016 Status changed from recruiting to completed.
- 14 Feb 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 14 Jun 2013 Planned initiation date changed from 1 May 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.